Connecticut Innovations

Connecticut Innovations (CI) is the state of Connecticut's strategic venture capital arm and the leading source of financing and ongoing support for innovative, growing companies. Operating as a quasi-public agency, CI provides equity and debt investments alongside strategic guidance and introductions to valuable business partners, helping promising early-stage and growth-stage companies across Connecticut thrive and scale. The organization serves as a critical bridge between emerging technology companies and the capital markets, offering flexible financing solutions tailored to every stage of business development. Connecticut Innovations manages several dedicated investment funds, each targeting distinct sectors and stages of company growth. The Connecticut Bioscience Innovation Fund is a $200 million evergreen fund focused exclusively on bioscience investment, supporting life sciences and biotech ventures across the state. The ClimateTech Fund is a $100 million vehicle that deploys capital and strategic support into early-stage and growth-stage companies operating at the intersection of environmental technology and commercial innovation. The Future Fund, a $50 million initiative, is dedicated to investing in new and diverse ideas, people, and industries within Connecticut, broadening the innovation ecosystem beyond traditional technology sectors. Most recently, CI launched the AI/Q Fund, a $50 million commitment targeting high-potential companies working at the intersection of artificial intelligence, quantum computing, and deep technology. This fund focuses on scalable commercial ventures that position Connecticut as a national hub for next-generation technology development. Beyond capital deployment, CI offers a suite of value-added services including brain trust connections, talent acquisition support, compliance resources, and ongoing operational guidance. The organization's portfolio spans multiple verticals including bioscience, climate technology, artificial intelligence, and general venture, with portfolio companies such as Bright Feeds, Curacity, Enko, and FlyteHealth. CI's team includes seasoned managing directors, investment associates, bioscience specialists, and operational professionals who work closely with portfolio companies to drive growth and long-term success.